Hospital Team

Teva launched its Irish Hospital and Speciality Products business in January 2007 with a small number of cytotoxic molecules. In the intervening years the Hospital Business has grown substantially, now providing a market leading range of cytotoxic's, IV anti-infective's, specialist hospital intravenous and solid dose products. In November 2010, Teva was pleased to launch its first in what promises to be a significant range of High Tech Biosimilar products. This new direction for Teva will undoubtedly help to ensure that direct savings are available for the Irish healthcare system well into the future.

The Hospital Business unit comprises of a specialised team all with extensive experience of providing quality products and services into the Irish Hospital sector over many years.

For further information or to arrange an appointment with your local Teva hospital representative, please click here.